Differential actions of typical and atypical antipsychotic drugs on dopamine release in the core and shell of the nucleus accumbens
- 1 March 1996
- journal article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 6 (1) , 29-38
- https://doi.org/10.1016/0924-977x(95)00056-u
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidolPharmacology Biochemistry and Behavior, 1994
- Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
- Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic actionMolecular and Cellular Neuroscience, 1992
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 1990
- Acute Effects of Typical and Atypical Antipsychotic Drugs on the Release of Dopamine from Prefrontal Cortex, Nucleus Accumbens, and Striatum of the Rat: An In Vivo Microdialysis StudyJournal of Neurochemistry, 1990
- Amperozide - a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviourBasic & Clinical Pharmacology & Toxicology, 1990
- Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons recordedin vivoBasic & Clinical Pharmacology & Toxicology, 1990
- Receptor binding properties of amperozideBasic & Clinical Pharmacology & Toxicology, 1990
- In vivo monitoring of dopamine release in the rat brain with differential normal pulse voltammetryAnalytical Chemistry, 1984
- Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine NeuronsScience, 1983